Cannell & Spears LLC cut its position in Ralliant Corporation (NYSE:RAL – Free Report) by 65.0% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 34,284 shares of the company’s stock after selling 63,737 shares during the period. Cannell & Spears LLC’s holdings in Ralliant were worth $1,499,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors and hedge funds have also recently modified their holdings of RAL. Arizona State Retirement System lifted its stake in shares of Ralliant by 1.2% during the 3rd quarter. Arizona State Retirement System now owns 33,566 shares of the company’s stock valued at $1,468,000 after buying an additional 413 shares in the last quarter. Manchester Capital Management LLC purchased a new stake in Ralliant in the 2nd quarter worth $29,000. Choreo LLC increased its stake in Ralliant by 9.9% in the 3rd quarter. Choreo LLC now owns 6,063 shares of the company’s stock worth $265,000 after buying an additional 546 shares in the last quarter. Westfuller Advisors LLC bought a new stake in Ralliant during the third quarter valued at about $26,000. Finally, GAMMA Investing LLC lifted its position in shares of Ralliant by 57.0% in the third quarter. GAMMA Investing LLC now owns 1,801 shares of the company’s stock valued at $79,000 after acquiring an additional 654 shares in the last quarter.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently weighed in on the company. Weiss Ratings lowered Ralliant from a “hold (c)” rating to a “sell (d)” rating in a research note on Thursday, February 5th. Zacks Research cut Ralliant from a “hold” rating to a “strong sell” rating in a report on Monday, February 9th. Barclays dropped their price target on Ralliant from $60.00 to $52.00 and set an “overweight” rating for the company in a research note on Monday, February 9th. Vertical Research raised shares of Ralliant from a “hold” rating to a “buy” rating and set a $45.00 price objective for the company in a report on Friday, February 6th. Finally, Truist Financial reduced their price objective on shares of Ralliant from $62.00 to $49.00 and set a “buy” rating on the stock in a research report on Friday, February 6th. Seven investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, Ralliant presently has an average rating of “Hold” and an average target price of $50.50.
Ralliant Trading Down 1.4%
RAL stock opened at $42.34 on Monday. The firm has a fifty day moving average price of $48.24 and a 200 day moving average price of $46.76. Ralliant Corporation has a fifty-two week low of $37.27 and a fifty-two week high of $57.02. The firm has a market cap of $4.73 billion and a PE ratio of 21.60. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.58 and a current ratio of 0.84.
Ralliant (NYSE:RAL – Get Free Report) last released its quarterly earnings results on Wednesday, February 4th. The company reported $0.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.67 by $0.02. The business had revenue of $554.60 million for the quarter, compared to analysts’ expectations of $543.04 million. The firm’s revenue for the quarter was up 1.2% compared to the same quarter last year. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.
Ralliant Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Monday, March 23rd. Stockholders of record on Monday, March 9th will be given a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a dividend yield of 0.5%. The ex-dividend date is Monday, March 9th. Ralliant’s dividend payout ratio is currently 10.20%.
Insider Activity
In related news, Director Anelise Angelino Sacks acquired 2,000 shares of Ralliant stock in a transaction on Monday, February 9th. The shares were bought at an average cost of $41.25 per share, with a total value of $82,500.00. Following the completion of the purchase, the director directly owned 5,403 shares of the company’s stock, valued at $222,873.75. The trade was a 58.77% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Kevin E. Bryant acquired 1,250 shares of the firm’s stock in a transaction on Friday, February 6th. The shares were bought at an average price of $39.97 per share, for a total transaction of $49,962.50. Following the completion of the transaction, the director owned 4,653 shares of the company’s stock, valued at approximately $185,980.41. This trade represents a 36.73% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last three months, insiders bought 8,145 shares of company stock worth $332,233.
About Ralliant
Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.
The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.
Recommended Stories
- Five stocks we like better than Ralliant
- The $8,000 Gold Call Every Retirement Saver Needs to Read Right Now
- A personal warning from Martin Weiss (Please read)
- Elon Musk: This Could Turn $100 into $100,000
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- America’s gold reserves are priced at $42. The real price is $6,000+.
Want to see what other hedge funds are holding RAL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ralliant Corporation (NYSE:RAL – Free Report).
Receive News & Ratings for Ralliant Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ralliant and related companies with MarketBeat.com's FREE daily email newsletter.
